Harvard Bioscience
HBIO
HBIO
67 hedge funds and large institutions have $8.39M invested in Harvard Bioscience in 2025 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 27 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
-24
Holders Change %
-26.37%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
19
Reduced
27
Closed
37
Calls
$61K
Puts
$10K
Net Calls
+$51K
Net Calls Change
+$50K
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$341K |
| 2 |
Millennium Management
New York
|
+$284K |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$61K |
| 4 |
MIM
Meros Investment Management
Dallas,
Texas
|
+$55.6K |
| 5 |
AE
AMH Equity
Great Neck,
New York
|
+$53.9K |
Top Sellers
| 1 |
RA
Royce & Associates
New York
|
-$1.01M |
| 2 |
BlackRock
New York
|
-$757K |
| 3 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$627K |
| 4 |
State Street
Boston,
Massachusetts
|
-$264K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$214K |
